COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology

Abroad (travel likely)Recruiting

Conditions

Pediatric Respiratory Diseases · COVID · Fatigue Post Viral

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Akershus universistetssykehus, Lørenskog, Norway
Contact: Study coordinator (Lise Beier Havdal) · lisebeierommen@gmail.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Coronavirus Infection (COVID-19) · Pulmonary Arterial Hypertension · Urinary Tract Infections in Children

Abroad (travel likely)Recruiting

Phoenix, United States · Little Rock, United States

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

COVID-19

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Los Angeles, United States

The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study

Vaping · Pregnancy Related · Pediatric Respiratory Diseases

Abroad (travel likely)Recruiting

Dublin, Ireland · Dublin, Ireland